Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.
Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, reflecting a metadata version change. This does not modify study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check29 days agoChange DetectedRemoved the temporary funding-status notice banner from the page. Core study information and links remain unchanged.SummaryDifference0.3%
- Check43 days agoChange DetectedResults have been posted for the study, and the record now includes updated study dates, status, and outcome measures. This adds visibility into trial findings and current completion status.SummaryDifference0.3%
- Check72 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check79 days agoChange Detected- Added version label v3.1.0. - Removed the resource entry for Plasma cell myeloma from Genetic and Rare Diseases Information Center.SummaryDifference0.4%
Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.